# Whey Protein Older Adults Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/whey-protein-older-adults-meta-analysis-evidence-review
Category: evidence-review
Summary: Whey Protein Older Adults Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-06-08
Reviewed by: Migaku Evidence Review
# Whey Protein Older Adults Meta-analysis: What the Evidence Says

## Quick Answer

Whey Protein Older Adults Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Explore the Optimal Treatment Regimen Across Combinations of Variate Protein Sources and Exercise Modalities and Its Associated Factors in Older Adults: A Network Meta-Analysis and Meta-Regression of Randomized Controlled Trials | systematic review | 1 | 2026-04-29 | 10.3390/nu18091409 |
| Exercise and nutritional interventions for sarcopenia-related fall prevention in older adults: An umbrella review | narrative review | 3 | 2026-06-01 | 10.1016/j.jnha.2026.100862 |

## What The Sources Report

- Such muscle attenuations can further contribute to strength deterioration and physical mobility decline, which in turn result in high risks of frailty and disability in the elderly. [Lin Che-Li (2026); evidence level 1]
- The main factor behind the development and progression of sarcopenia is thought to be a reduced muscle protein synthesis response (i.e., myogenesis) and a negative muscle balance in older adults. [Lin Che-Li (2026); evidence level 1]
- Contemporary diagnostic frameworks established by the European Working Group on Sarcopenia in Older People (EWGSOP) prioritize muscle strength assessment as the cardinal criterion, supplemented by confirmatory evidence of diminished muscle quality or quantity and compromised physical performance. [Dharmansyah Dhika (2026); evidence level 3]
- Emerging evidence establishes sarcopenia as a pivotal modifiable risk factor for falls. [Dharmansyah Dhika (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For whey protein older adults meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Lin Che-Li (2026). Explore the Optimal Treatment Regimen Across Combinations of Variate Protein Sources and Exercise Modalities and Its Associated Factors in Older Adults: A Network Meta-Analysis and Meta-Regression of Randomized Controlled Trials. DOI: 10.3390/nu18091409. PMCID: PMC13165454. PMID: 42124009. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165454/
- Dharmansyah Dhika (2026). Exercise and nutritional interventions for sarcopenia-related fall prevention in older adults: An umbrella review. DOI: 10.1016/j.jnha.2026.100862. PMCID: PMC13235354. PMID: 42208412. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC13235354/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.